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  Wnk kinase maintains cell volume, regulating various transporters such as sodium-chloride cotransporter, 
potassium-chloride cotransporter, and sodium-potassium-chloride cotransporter 1 (NKCC1) through the 
phosphorylation of oxidative stress responsive kinase 1 (OSR1) and STE20/SPS1-related proline/alanine-rich 
kinase (SPAK). However, the activating mechanism of Wnk kinase in specific tissues and specific 
conditions is broadly unclear. In the present study, we used a human salivary gland (HSG) cell line 
as a model and showed that Ca2+ may have a role in regulating Wnk kinase in the HSG cell line. Through 
this study, we found that the HSG cell line expressed molecules participating in the WNK-OSR1-NKCC 
pathway, such as Wnk1, Wnk4, OSR1, SPAK, and NKCC1. The HSG cell line showed an intracellular 
Ca2+ concentration ([Ca2+]i) increase in response to hypotonic stimulation, and the response was synchronized 
with the phosphorylation of OSR1. Interestingly, when we inhibited the hypotonically induced [Ca2+]i 
increase with nonspecific Ca2+ channel blockers such as 2-aminoethoxydiphenyl borate, gadolinium, and 
lanthanum, the phosphorylated OSR1 level was also diminished. Moreover, a cyclopiazonic acid-induced 
passive [Ca2+]i elevation was evoked by the phosphorylation of OSR1, and the amount of phosphorylated 
OSR1 decreased when the cells were treated with BAPTA, a Ca2+ chelator. Finally, through that process, 
NKCC1 activity also decreased to maintain the cell volume in the HSG cell line. These results indicate 
that Ca2+ may regulate the WNK-OSR1 pathway and NKCC1 activity in the HSG cell line. This is 
the first demonstration that indicates upstream Ca2+ regulation of the WNK-OSR1 pathway in intact 
cells. 
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INTRODUCTION
  Wnk, with no lysine, means that there is a lack of a con-
served lysine residue in subcatalytic domain II, which is 
required for ATP binding [1]. Wnk kinases (WNKs) are ser-
ine/threonine protein kinases and are well conserved in 
many species from fungi to mammals [1]. Previous work 
by another group revealed that four types of WNKs are ex-
pressed in humans: Wnk1, Wnk2, Wnk3, and Wnk4 [2]. 
After the finding that mutations in Wnk1 and Wnk4 cause 
the disease pseudohypoaldosteronism type II (PHA II, 
OMIM no. 145260), many subsequent studies followed [3]. 
PHA II involves hypertension, with increased NaCl re-
absorption and impaired K+ and H+ excretion [3]. Those 
clinical symptoms of PHA II indicate that WNKs perform 
roles in the kidney [4]. Consequently, early Wnk studies 
focused on transporters or channels located in the kidney 
and found that Wnk4 regulates the renal outer medullary 
potassium channel [5], the sodium-chloride cotransporter 
(NCC) [6,7], the sodium-potassium-chloride cotransporter 
(NKCC) [6-8], and claudin [9,10] which is a component of 
tight junctions. Thereafter, it was found that activated 
Wnk1 phosphorylates oxidative stress responsive kinase 1 
(OSR1) and STE20/SPS1-related proline/alanine-rich kin-
ase (SPAK) and that activated OSR1/SPAK phosphorylates 
the N-terminus of NKCC, which is required for activation 
[6,8]. WNK is activated via autophosphorylation and regu-
lated by the presence of an autoinhibitory domain [11]. 
Moreover, the Wnk autoinhibitory domain is conserved in 
all of the WNKs [11], and the autoinhibitory domain of 
Wnk1 restrains not only the autophosphorylation of Wnk1 
but also that of Wnk2 and Wnk4 [12].
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  Although the presence of autophosphorylation/autoinhibition 
was discovered early, the regulating mechanism of WNKs 
is still poorly understood [13-15]. Several mechanisms regu-
lating WNKs have been revealed [13]. One is ubiquitination 
through scaffolding proteins such as CUL3, KLHL2, and 
KLHL3 [16-22]. Another regulating system is phosphorylation 
modulated by phosphatidylinositol 3-kinase/Akt (PIP3K/Akt) 
[23] and apoptosis signal-regulating kinase 3 (ASK3) [24,25]. 
The activation of WNKs in low Cl- conditions is the most 
direct regulation of WNKs [13]. Although the presence of 
SPAK/OSR1 phosphorylation induced by low Cl- was re-
vealed early [26], it remains a mystery how WNKs sense 
the low Cl-, and the possibility of there being another Cl- 
sensor that regulates WNKs still exists. Recently, the direct 
binding of Cl- to a catalytic domain of Wnk1 was revealed 
by crystallography [27]. Nonetheless, an upstream regu-
lator of WNKs is still not enough to explain all of the regu-
latory machinery.
  Ca2+ is a well-known second messenger that mediates 
various cell functions [28]. It is well known that hypotonicity 
induces the elevation of intracellular Ca2+ levels through 
the Ca2+ channels located in the plasma membrane. In addi-
tion, Ca2+-activated Cl- channels are well defined in the sali-
vary glands. Therefore, we hypothesized that Ca2+ might 
regulate the WNK-OSR1 pathway, and we found that alter-
ations of the intracellular Ca2+ level determined the phos-
phorylation of OSR1 and the activity of NKCC1 in a human 
salivary gland (HSG) cell line.
METHODS
Materials and antibodies
  HSG cell line was a gift from Dr. Kyungpyo Park in Seoul 
National University. Rabbit polyclonal p-OSR1 antibody 
was purchased from Millipore (Cat#07-2273). Rabbit poly-
clonal OSR1 antibody was purchased from Cell signaling 
(#3729). Cyclopiazonic acid was from Enzo life science (Far-
mingdale, NY, USA). 2-Aminoethoxydiphenyl borate was 
from Tocris (Bristol, BS11 0QL, UK). Trypsin/EDTA, Fetal 
Bovine Serum, and 100X Antibiotic-Antimycotic was from 
Gibco (Carlsbad, CA, USA). BCECF-AM, BAPTA-AM, and 
Pluronic acid F-127 was from Life technologies (Carlsbad, 
CA, USA). Fura2-AM was from Teflabs (Austin, TX, USA).  
NaCl, NH4Cl was from Duksan (Ansan, Gyeonggi-do, Korea). 
KCl, EGTA, Glucose, and HEPES was from Amresco (Solon, 
OH, USA). Collagenase P was from Roche (Indiana polis, 
IN, USA). All other chemicals include MgCl2, CaCl2, Trypsin 
inhibitor, sodium pyruvate, gadolinium, lanthanum, and 
ruthenium red was from Sigma-Aldrich (St. Louis, MO, USA).
Isolation of salivary gland cell
  ICR mice were purchased from (KOATEC, Korea). All ex-
periments were performed on adult male ICR mice (6-8 
weeks of age) that were maintained on a 12h day/night cy-
cle with normal mouse chow and water provided ad libitum. 
The animal studies were performed after receiving approval 
of the Institutional Animal Care and Use Committee (IACUC) 
in Yonsei University (IACUC approval no. 2014-0067). Mice 
were sacrificed by cervical dislocation under CO2 anesthesia. 
The cells were prepared from the parotid gland and sub-
mandibular gland of ICR mice by limited collagenase diges-
tion as previously described [29]. Following isolation, the 
acinar cells were suspended in an extracellular physiologic 
salt solution (PSS), the composition of which was as follows 
(in mm): 140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 HEPES, 
and 10 Glucose, adjusted to pH 7.4 with 5 N NaOH and 
to 310 mOsm with 5 M NaCl.
Cell culture
  HSG cell-line was maintained with high-glucose Dulbecco’s 
Modified Eagle’s medium with 10% FBS and 1X Antibio-
tic-Antimycotic (Gibco, CA, USA) in 95% CO2, 5% O2, 37oC 
incubator. Subculture was done with Trypsin/ EDTA when 
cells are confluent. Cells that used in the calcium imaging 
and NKCC1 activity measurement were cultured on the 24×24 
mm size of cover glass. 
Reverse-transcriptional PCR
  Total RNA was extracted from isolated pancreatic acinar 
cells using Trizol reagent (Sigma-Aldrich) according to the 
manufacturer's instructions. RT-PCR was performed using 
a SuperScript III RT kit (Sigma-Aldrich, USA) and oli-
go-dTs (Fermentas, MA, USA). For PCR analysis of the fol-
lowing primers were used: 
  hWnk1 (forward: 5'-AATCCAGTGCTTCCCAGACA-3', re-
verse: 5'-TCTGTTGGCTGCTCACTCGAGATT-3'), hWnk4 (for-
ward: 5'-AGCTGCGTAAAGCAAGGGAATTGG-3', reverse: 
5'-TTTGTCCCATCCCTTCTCCCACAT-3'), hOSR1 (forward: 
5'-AGGTTCCAGTGGGCGTCTTCATAA-3', reverse: 5'-AGG-
CCAGCAGAAATGAGTTCCTGA-3'), hSPAK (forward: 5'-A-
TTCAAGCCATGAGTCAGTGCAGC-3', reverse: 5'-GCGCT-
GCTCCTGTTGCTAATTCAA-3'), hNKCC1 (forward: 5'-AA-
GCAGTCCTTGTTCCTATGGCCT-3', reverse: 5'-GCAATGC-
AGCCCACCAGTTAATGA-3'), hGAPDH (forward: 5'-CGG-
AGTCAACGGATTTGGTCGTAT-3', reverse: 5'-AGCCTTCT-
CCATGGTGGTGAAGAC-3')
  PCR reaction was performed using EmeraldAmp GT PCR 
Master Mix (Takara, Shiga, Japan). PCR condition was ini-
tiated by a 5 min incubation of the samples at 94oC, preceded 
by 30 (Wnk1, Wnk4), 35 (OSR1, SPAK, NKCC1, GAPDH) 
cycles of 30 sec at 94oC, 30 sec for annealing (Wnk1 57oC, 
Wnk4 60oC, OSR1 58oC, SPAK 59oC, NKCC 58oC, GAPDH 
58oC), and 30 sec at 72oC. After 30 (Wnk1, Wnk4), 35 (OSR1, 
SPAK, NKCC1, GAPDH) cycles, samples were incubated 
for 10 min at 72oC for complete extension. No reverse tran-
scription control was performed using the same protocol, 
except for using reverse transcriptase.
Measurement of intracellular Ca2+
  Cultured on 24×24 mm coverglass, with density of 1.5×106 
cells/ml with 48 h were loaded with 4 μM Fura-2/AM and 
0.05% Pluronic acid F-127 for 30 min in PSS at room 
temperature. Fura-2/AM fluorescence was measured at an 
excitation wavelengths of 340/380 nm, and emission was 
measured at 510 nm (ratio=F340/F380) using an imaging 
system (Molecular Devices, CA, USA). The emitted fluo-
rescence was monitored using a CCD camera (CoolSNAP HQ, 
AZ, USA) attached to an inverted microscope. Fluorescence 
images were obtained at 2 sec intervals. All data were ana-
lyzed using the MetaFluor software (Molecular Devices, 
Downingtown, PA, USA).
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Fig. 1. Phosphorylated OSR1 induced by hypotonicity and mRNA 
expression in a HSG cell line and phosphorylation of OSR1 in an 
isolated salivary gland acinar cell. (A) RT-PCR confirmed the 
expression of Wnk1, Wnk4, OSR1, SPAK, and NKCC1 at mRNA 
level. GAPDH expression was used as a control. (B) A hypotonic 
solution (215 mOsm) induced an increase in phosphorylated OSR1 
(p-OSR1) in the HSG cell line (upper panel) and p-OSR1 in the 
parotid gland (PG) and submandibular gland (SMG) from ICR mice 
(lower panel). (C) The p-OSR1 level in the HSG cell line was 
normalized with the total OSR1 (right panel). HSG cell line n=3, 
mouse salivary gland acinar cell n=1, *p＜0.05.
Fig. 2. Hypotonic stress-induced intracellular Ca2+ increases. The 
intracellular Ca2+ concentration ([Ca2+]i) was shown as the Fura2 
intensity ratio of A340/A380. (A) A [Ca2+]i increase was observed 
when the cells were treated with a hypotonic solution, and the 
increased [Ca2+]i was diminished after the removal of extracellular 
Ca2+. (B) Pretreatment with 2APB, Gd3+, and La3+ reduced the 
[Ca2+]i induced by the hypotonic stimulation, and after washout of 
the blockers, the hypotonic stress-induced [Ca2+]i was recapitulated. 
(C) 4α-PDD evoked an increase in the [Ca2+]i. All the graphs show 
a representative trace, n=20∼30 cells.
Immunoblotting
  Protein extracts were prepared from HSG cell-line and 
ICR salivary glands as follows. Cells were lysed in a buffer 
containing (in mm): 150 NaCl, 10 Tris (pH 7.8 with HCl), 
1 EDTA, 1% NP-40, 0.1% SDS, and a protease inhibitor mix-
ture (2 Na3VO4, 10 NaF, 10 μg/ml leupeptin, and 10 μg/ml 
phenylmethylsulfonyl fluoride). The samples were probed 
overnight with 1:2,000 dilutions of antibodies against p-OSR1, 
OSR1 at 4oC and then separated by SDS-PAGE.
Measurement of intracellular pH (pHi) and NKCC activity
  pHi was measured using pH sensitive fluorescent dye, 
BCECF-AM. Cells were loaded with 2.5 μM BCECF-AM 
in PSS for 30 min at room temperature. The fluorescence 
at excitation wavelength of 490 nm and 440 nm was re-
corded using a CCD camera (CoolSNAP HQ, AZ, USA). 
Fluorescence images were obtained at 2 sec intervals. All 
data were analyzed using the MetaFluor software (Molecular 
Devices, Downingtown, PA, USA). 
  Na+-K+-2Cl- cotransporter (NKCC) activity was measured 
from the pHi decrease induced by the intracellular uptake 
of NH4+ using the methods of Evans and Turner [30] with 
modifications. Adding NH4Cl 20 mM in the extracellular 
solution induce robust increase of pHi due to diffusion of 
NH3 (Fig. 4E). Thereafter, pHi is getting decreased by influx 
of NH4+, because NH4+ acts as a surrogate of K+ in the 
NKCC. To discriminate only the NKCC activity, 100 μM 
bumetanide applied. Slope inclination was measured from 
1 min to 3 min after solution change.  
Data analysis and statistics
  Results are expressed as the mean±SEM. The statistical 
significance of differences between groups was determined 
using the Student's t-test. In statistical tests, p-values less 
than 0.05 were considered significant.
RESULTS
Expression and activation of Wnk kinase in the human 
salivary gland cell line
  The expression of WNKs in the HSG cell line was pre-
viously unknown. Therefore, we first investigated WNK 
and its substrates, OSR1 and SPAK. Reverse-transcription 
PCR was performed, and we confirmed the mRNA ex-
pression of Wnk1, Wnk4, OSR1, SPAK, and NKCC1 in an 
HSG cell line (Fig. 1A). The Wnk4 expression level was low-
er than the Wnk1 expression level (Fig. 1A). The next step 
was the measurement of OSR1 phosphorylation at serine 
325 by immunoblotting. The phosphorylation of OSR1 at 
serine 325 to form p-OSR1, the activated form of OSR1, 
is mediated by WNK. Hence, the elevation of p-OSR1 levels 
is considered indirect evidence showing the activation of 
WNK, because OSR1 is a main substrate of WNK. We ob-
served an increase in the p-OSR1 level after 15 min of hypo-
tonic (215 mOsm) stimulation at 37oC (Fig. 1B, upper pan-
el). The hypotonic stimulation was induced using a hypo-
tonic solution (HS) that reduced only the NaCl content of 
a physiologic salt solution (PSS). We observed a p-OSR1 
increase in isolated parotid gland acini and also in sub-
mandibular gland acini from an ICR mouse (Fig. 1B. lower 
panel). These data suggest that the HSG cell line can imi-
tate hypotonically induced OSR1 activation. 
Ca2+ signaling by hypotonic stress in the HSG cell line
  Extracellular HS treatment induced an increase in the 
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Fig. 4. Down-regulation of NKCC 
activity is induced by hypotonic stress 
in a HSG cell line. Intracellular pH 
indicated by the BCECF signal ratio. 
(A) A decline in the rate after 
bumetanide (100 μM) treatment was 
decreased in an isotonic solution (310 
mOsm); however, (B) after hypotonic 
stimulation (215 mOsm), the degree of 
the decline in the rate was reduced. 
(C) Chelating [Ca2+]i with 25 μM
BAPTA-AM treatment restored the 
bumetanide-sensitive modification of 
the BCECF ratio. (A∼C) The narrow 
black line represents a trend line 
indicating the slope of the pH 
declination. The alteration of the slope 
by treatment by 100 μM bumetanide 
is emphasized in the box. (D) The 
shifting slope of the declination was 
expressed by the fold change. (E) 
Schematic diagram that shows role of 
NH4Cl in the intracellular pH 
modification. All the traces are 
representative graphs, with n=25∼35 
cells in each experiment. *p＜0.05.
Fig. 3. Phosphorylation of OSR1 with various Ca2+ signaling-related
drugs. (A) Pretreatment with 25 μM BAPTA/AM for 20 min 
followed by treatment with a hypotonic solution (215 mOsm) for 
10 min. The fold change of the p-OSR1/OSR1 between control and 
BAPTA-loaded cells was statistically significant in the hypotonic 
stimulation. (B) Before hypotonic stimulation, each of the blockers 
was incubated for 20 min at 37oC, and then the cells were treated 
with the hypotonic solution for 10 min. 2APB 100 μM, RR 10 μM, 
Gd3+ 10 μM, and La3+ 10 μM was applied. (C, D) Up-regulated 
p-OSR1 was observed with both 25 μM CPA and 10 μM 4α-PDD 
applied in an isotonic solution (310 mOsm) *p＜0.05. n=3 each.
intracellular Ca2+ concentration ([Ca2+]i), and was abolished 
with the depletion of Ca2+ ions in the extracellular solution 
(Fig. 2A), suggesting that the increased Ca2+ signal origi-
nated from the outside of the cell. To define how the Ca2+ 
influx was mediated by extracellular Ca2+ ions, we used 10 
μM ruthenium red (RR), 100 μM 2-aminoethoxydiphenyl 
borate (2APB), 10 μM gadolinium (Gd3+), and 10 μM lan-
thanum (La3+) as blockers. After 5 min of pre-incubation 
with 2APB, Gd3+, and La3+, hypotonic stimulation did not 
evoke an elevation in the [Ca2+]i. However, RR could not 
inhibit the [Ca2+]i increase (Fig. 2B). When we added 10 
μM 4α-phorbol 12, 13-didecanoate (4α-PDD) to the iso-
tonic PSS (310 mOsm), we observed similar patterns of 
[Ca2+]i increase (Fig. 2C).
Ca2+ signaling is related to OSR1 phosphorylation
  BAPTA is a high-affinity Ca2+ chelator that acts rapidly. 
When we loaded 25 μM BAPTA-AM, which is an acetome-
thoxy ester conjugate of BAPTA, 20 min prior to the hypo-
tonic stimulation, the p-OSR1 level was reduced compared 
with that in a control after 10 min of hypo-osmotic stress 
(Fig. 3A, left panel). The fold change of the p-OSR1/total OSR1 
intensity was 2.88±0.15 in 215 mOsm, 1.51±0.02 in 215 
mOsm+BAPTA, and 1.06±0.01 in 310 mOsm+BAPTA (Fig. 
3A, right panel). This result indicates that p-OSR1 may be 
regulated by upstream Ca2+ ions. The 4α-PDD-induced 
p-OSR1 level was also increased 10 min after treatment and 
diminished less than that in the control after 1 h (Fig. 3C). 
In agreement with the Ca2+ signaling pattern, the p-OSR1 
level was reduced following a 20 min pre-incubation with 
the blockers 2APB, Gd3+, and La3+  (Fig. 3B). RR could not 
inhibit the hypotonic-induced [Ca2+]i increase in the HSG 
cell line (Fig. 2B, second panel from the top), and the 
p-OSR1 level was increased in the RR pre-incubation only 
(Fig. 3B). The Ca2+ release from the endoplasmic reticulum 
(ER) induced by 25 μM cyclopiazonic acid (CPA) could also 
elevate the p-OSR1 level (Fig. 3D). 
NKCC1 activity is reduced under hypotonic stress
  The activation of OSR1 could affect the various trans-
porters in the plasma membrane, such as the NCC, the 
K+-Cl- cotransporter (KCC), and the NKCC. In the present 
study, we measured NKCC activity using pH changes in 
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the HSG cells. The traces in Fig. 4A-C show the BCECF 
ratio of emitting wave intensity in the excitation wave-
lengths 490 nm and 440 nm. Thus, the value of the BCECF 
ratio indicates the intracellular pH (pHi). Fig. 4E shows the 
scheme of the NH4Cl treatment. When 20 mm NH4Cl was 
added to the extracellular solution, with the substitution 
of NaCl to maintain the osmolarity, the influx of NH3 cause 
pH increase. After that, through NKCC1 activity, which 
carries NH4+ as a surrogate of K+, the pH in the solution 
acidified. Bumetanide (100 μM) can inhibit NKCC activity. 
Therefore, the difference in the slope inclination between 
the NH4Cl treatment and the bumetanide treatment was 
assessed to measure the NKCC1 activity by quantifying the 
acidification rate. The greatest slope change was with 100 
μM bumetanide in the isotonic solution (310 mOsm; Fig. 
4A). After pre-incubation in HS (215 mOsm) for 5 min, the 
fold change in the slope was 0.67±0.05 (Fig. 4B), which was 
statistically significant (Fig. 4D). After pre-incubation with 
25 μM BAPTA-AM in HS, the decreased fold change in 
the slope was restored (Fig. 4C, D).
DISCUSSION
  In the present study, we found that the phosphorylation 
of OSR1 is regulated by the [Ca2+]i. This was a unique find-
ing of our study. In other articles, it was shown by using 
a kinase assay that Wnk4 kinase activity increased depend-
ing on the Ca2+ concentration in vitro, and that effect was 
diminished by the substitution of acidic amino acid residues 
such as E562 and D564 in Wnk4 [31]. Tacrolimus, which 
is a calcineurin inhibitor, induced Wnk3, Wnk4, and SPAK 
expression in mouse kidney [32]. Those previous studies 
support our findings that p-OSR1 is regulated by the 
[Ca2+]i.
  The other issue in this study is that a source of increased 
Ca2+ triggered the phosphorylation of OSR1. When we re-
moved the external Ca2+ from the hypotonic solution (Fig. 
2A), the [Ca2+]i was reduced to the baseline. That result 
shows that the increased [Ca2+]i in the HSG cell line origi-
nated from the influx of external calcium. 2APB, an in-
hibitor of Ca2+ channels [33,34], was used to block the influx 
of Ca2+. 2APB also inhibits the IP3 induced Ca2+ increase. 
However, even though 2APB acts as an inhibitor of either 
IP3 induced Ca2+ increase or nonselective cation channel, 
the outcome of 2APB treatment is an inhibition of [Ca2+]i 
increase. In the results pretreatment with 2APB inhibited 
the elevation of the [Ca2+]i and reduced the level of p-OSR1 
induced by hypotonic stress in the HSG cell line (Fig. 2B, 
3B). Furthermore, nonselective cation channel blockers, 
like Gd3+ and La3+, also inhibited the [Ca2+]i and the p-OSR1 
level under hypotonic stress in the HSG cell line (Fig. 2B, 
3B). Those results indicate external Ca2+ influx mediated 
by Ca2+ channels sensitive to 2APB, Gd3+, and La3+ in the 
HSG cell line. Interestingly, treatment with 4α-PDD, which 
is a selective activator of TRPV4, displayed Ca2+ signaling 
patterns similar to those displayed by hypotonic stim-
ulation [35,36]; TRPV4 is a well-known Ca2+ permeable 
channel activated by hypotonic stress [37]. Thus, a 
TRPV4-induced [Ca2+]i appears to be one potent channel 
that mediates the OSR1 pathway in the HSG cell line, but 
that hypothesis requires more experiments to be confirmed. 
Likewise, another TRP channels, such as TRPC3, and TRPM4 
also involved hypotonicity stimulated Ca2+ influx in the 
HSG cell line, but we have not included in this paper. It 
was unexpected that RR could not inhibit the [Ca2+]i and 
the p-OSR1 level. That result suggests that RR-resistant 
Ca2+ channels play a role in the HSG cell line. However, 
to solve that remaining question about RR, another inves-
tigation is required.
  The next question is whether the Ca2+ performed as an 
upstream regulator or as a downstream messenger of OSR1 
phosphorylation. Because BAPTA is a rapid and high-affin-
ity chelator of Ca2+, it is regarded as a highly efficient chela-
tor that blocks the action of Ca2+ in the cell [38]. When 
the [Ca2+]i was chelated by BAPTA during the hypotonic 
stimulation of the HSG cell line, the p-OSR1 level was de-
creased (Fig. 3A). That suggests that Ca2+ is an upstream 
regulator of p-OSR1. Ca2+ is more important than the me-
chanical membrane stretching induced by the HS. It is in-
ferred from the facts that the [Ca2+]i increases with 4α-PDD 
(Fig. 3D), and CPA (Fig. 3C) also resulted in increased 
p-OSR1 levels. However, the CPA induced less p-OSR1 than 
did the hypotonic stimulation. That could be explained by 
the localization of the WNKs near the plasma membrane [1].
  Although, Ca2+ regulates OSR1 through phosphorylation, 
it is still unclear whether OSR1 is directly or indirectly 
regulated by the WNKs. Ca2+ was required to show the kin-
ase activity of Wnk4. In the intact cell, however, remaining 
kinase activity appeared at very low Ca2+ concentrations, 
below 1 nM [31]. Moreover, it is well known that WNKs 
exhibit autoinhibition and autophosphorylation [11,12], and 
role of low Cl- in the activation of WNKs was revealed by 
crystallography [27]. Furthermore, it is well known that 
Ca2+-activated Cl- channels, like TMEM16A, are expressed 
in the apical membranes of salivary gland acinar cells [39]. 
Therefore, we assumed that TMEM16A activated by an ele-
vated [Ca2+]i contributes to the local depletion of Cl- at the 
microdomain level, and that the depletion of Cl- leads to 
the activation of the WNK-OSR1 pathway. However, more 
investigations will be required to test that model.
  The popular effectors of activated OSR1 are the NCC, 
the KCC, and the NKCC [13-15]. Furthermore, the NKCC 
is the essential molecule that maintains Cl- homeostasis in 
salivary gland acinar cells [39]. For that reason, we inves-
tigated the alteration of NKCC activity in the HSG cell line 
(Fig. 4). After hypotonic stimulation, NKCC activity was 
reduced in the HSG cell line and was recapitulated by che-
lating Ca2+ through BAPTA pretreatment (Fig. 4D). It is 
still controversial whether activated OSR1 contributes to 
the activation or to the inactivation of NKCC, depending 
on the cell type [24,40]. In terms of volume homeostasis, 
we think that the inhibition of NKCC requires cells to de-
crease the intracellular ion osmolarity to maintain the cell 
volume. 
  In conclusion, we found that Ca2+ regulates the WNK- 
OSR1-NKCC pathway. This is the first study to demon-
strate the Ca2+-mediated WNK-OSR1-NKCC pathway in an 
intact HSG cell line. We hope that these results will help 
to clarify the regulatory mechanism of the WNK-OSR1 
pathway and further our understanding of the mechanism 
of salivary secretion.
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